Phosphatidylethanolamine lipids secreted by CD8⁺ T cells mediate cytotoxic immunity

The immune system relies on a specialized squad of white blood cells known as CD8+ T cells to patrol the body and eliminate threats. These cells act as precise assassins, identifying infected or cancerous cells and destroying them to maintain health. For decades, scientists understood how these cells delivered their lethal blow primarily through proteins. They knew that T cells could release toxic proteins like perforin, which punches holes in a target cell's wall, or granzymes, which enter through those holes to trigger self-destruction. They also knew T cells could use surface proteins to signal death or release chemical messengers that disrupt a cell's internal machinery. This protein-based model of immunity was considered the complete story of how T cells kill. However, the possibility that these cells might use other types of molecules, such as fats, to carry out their mission remained largely unexplored. Understanding the full range of tools T cells possess is critical, because tumors and viruses often evolve ways to hide from or resist these known protein attacks. If the immune system has hidden weapons, discovering them could reveal new ways to fight diseases that currently evade standard treatments.

A team of researchers has now uncovered a previously unknown mechanism where CD8+ T cells use a specific type of fat molecule to kill their targets. These molecules are called phosphatidylethanolamine, or PE lipids. When T cells are activated to fight, they do not just release proteins; they also manufacture large amounts of these cone-shaped fat molecules and package them into tiny, bubble-like sacs called vesicles. The researchers found that these vesicles travel to the point where the T cell touches the target cell, known as the immunological synapse, and release their contents. Once inside the target cell, the PE lipids are transported to a specific internal structure called the endoplasmic reticulum, which is responsible for making proteins and fats. The sudden influx of these cone-shaped lipids overwhelms the endoplasmic reticulum, causing it to stretch and bend in ways it cannot handle. This physical stress triggers a chain reaction that leads to the target cell's death.

The study demonstrated that this fat-based killing method works independently of the traditional protein weapons. Even when the researchers genetically removed the ability of T cells to produce perforin, granzymes, or other known toxic proteins, the cells could still kill tumor cells effectively. The secret lay in the lipids. The researchers showed that if they blocked the production of PE lipids in the T cells, the cells lost much of their ability to kill, even though their protein weapons were still intact. Conversely, if they prevented the target cells from taking up these lipids, the T cells could no longer kill them, regardless of how many toxic proteins they released. This suggests that the fat molecules are not just a side effect but a primary driver of the immune attack.

To understand how this works, the scientists traced the journey of these molecules. They found that activated T cells switch on a specific factory inside their own cells to produce PE lipids from scratch. These newly made lipids are gathered into vesicles that are distinct from the sacs containing the traditional protein toxins. These lipid vesicles move rapidly to the contact point with the enemy cell and are released. The target cell then absorbs these vesicles. Inside the target, a specific transport protein called Esyt1 acts like a shuttle, moving the PE lipids from the cell surface to the endoplasmic reticulum. Because PE lipids have a unique cone shape, packing too many of them into the flat sheets of the endoplasmic reticulum causes the structure to warp and stress. This stress activates a cellular alarm system that ultimately shuts down the cell. The researchers confirmed that this process is distinct from other forms of cell death, such as those caused by protein toxins or oxidative damage, and relies specifically on this lipid overload.

The findings also revealed that this mechanism is not limited to mouse cells but works in human cells as well. The researchers tested human immune cells engineered to fight cancer, known as CAR-T cells, and found they also produce and secrete these toxic PE lipids. In experiments with human cancer cells, the same pattern emerged: the lipids caused stress in the endoplasmic reticulum and led to cell death. The study further showed that this method is effective against a wide range of targets, including different types of cancer cells and cells infected with viruses. Importantly, the researchers discovered that the toxicity of these lipids depends on their ratio to another type of fat called phosphatidylcholine. In the blood, these fats exist in a ratio that prevents them from harming healthy cells. However, the T cells release the toxic lipids in a way that creates a high concentration relative to the other fats, ensuring they only kill the intended targets.

The potential application of this discovery lies in enhancing current cancer therapies. The researchers tested a strategy to boost the production of these lipids in T cells before using them to treat cancer. By feeding the T cells a specific building block called ethanolamine, they increased the amount of PE lipids the cells could produce. When these enhanced cells were introduced into mice with tumors, the tumors shrank more effectively, and the mice survived longer. This improvement occurred even in cases where the traditional protein weapons were missing, proving that the lipid pathway is a powerful and independent tool. The study suggests that manipulating this lipid pathway could make immune therapies more robust, offering a new way to overcome the resistance that some tumors develop against standard treatments.

This work fundamentally changes the view of how the immune system operates. It moves beyond the idea that proteins are the sole agents of destruction and establishes that lipids can serve as potent weapons in the immune arsenal. The researchers have mapped out a complete pathway, from the production of the fat molecules in the T cell to their delivery and the specific stress they cause in the target cell. By identifying the key players, such as the transport protein Esyt1 and the stress sensor Chop, the study provides a clear map of this new biological process. While the research was conducted in laboratory settings and animal models, the consistency of the results across mouse and human cells indicates that this is a genuine and significant mechanism in human immunity. The discovery opens a new chapter in understanding how the body defends itself, suggesting that the battle against disease is fought not just with protein swords, but also with lipid shields that can overwhelm the enemy from within.